Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Food dyes are known to have a wide range of impacts on health, such as cancer risks, behavioral problems in children, and ...

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

The Revell family hoped a gene therapy could buy time for their sons, who have a rare and fatal disease. After two patients ...

From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.

This isn't the first natural color that the FDA has approved this year.Key pointsOn Monday, July 14, the FDA announced that it has approved the use of the natural color additive gardenia (genipin) ...

The US Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity disorder (ADHD) medications.

REGN scores FDA approval for Lynozyfic in tough-to-treat multiple myeloma, bolstering its oncology pipeline amid Eylea headwinds.

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology indications and cancer types.

The FDA has removed the Risk Evaluation and Mitigation Strategies (REMS) requirements for currently approved BCMA- and CD19-directed CAR-T therapies, the agency said Thursday.

Price differences are especially pertinent with these weight loss drugs, which are officially called glucagon-like peptide-1 ...